Folate receptor mediated intracellular gene delivery using the charge changing solid lipid nanoparticles Folate receptor mediated intracellular gene delivery Z. Liu et al.

Drug Delivery

Volumn 16, Issue 6, 2009, Pages 341-347

  Liu, Zhongbing ^a   Zhong, Zhirong ^a,b   Peng, Gang ^a   Wang, Shurong ^a   Du, Xi ^a   Yan, Dongmei ^a   Zhang, Zhirong ^b   He, Qin ^b   Liu, Jie ^b  

^a Lu Zhou Medical College   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

DNA; Folate receptor; Folate chitosan; Gene delivery; Solid lipid nanoparticles

Indexed keywords

CARBAMIC ACID; CHITOSAN; CHOLEST 5 EN 3BETA YL[2 [(CARBOXYMETHYL)DITHIO] 1 IMINOBUTYL]AMINO]ETHYL]CARBAMATE; CHOLESTEROL DERIVATIVE; DISULFIDE; DITHIOTHREITOL; FOLATE RECEPTOR; FOLIC ACID; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REPORTER GENE; REVERSE MICELLE; SCANNING ELECTRON MICROSCOPY; SERUM; ZETA POTENTIAL;

CARRIER PROTEINS; CELL LINE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; INTRACELLULAR FLUID; LIPIDS; NANOPARTICLES; RECEPTORS, CELL SURFACE;

EID: 70350625385     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540903047387     Document Type: Article

References (32)

1. Antony, A.C. (1996). Folate receptors. Annu Rev Nutr, 16, 501-521
2. Benns, J.M., Maheshwari, A., Furgeson, D.Y., Mahato, R.I., Kim, S.W. (2001). Folate-PEG-Folate-graft-polyethylenimine-based gene delivery. J Drug Target, 9, 123-139
3. Chan, P., Kurisawa, M., Chung, J.E., Yang, Y.Y. (2007). Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery. Biomaterials, 28, 540-549
4. Cheung, S.T., Tsui, T.Y., Wang, W.L., Yang, Z.F., Wong, S.Y., Ip, Y.C., Luk, J., Fan, S.T. (2002). Liver as an ideal target for gene therapy: Expression of CTLA4Ig by retroviral gene transfer. J Gastroenterol Hepatol, 17, 1008-1014
5. Cichon, G., Schmidt, H.H., Benhidjeb, T., Löser, P., Ziemer, S., Haas, R., Grewe, N., Schnieders, F., Heeren, J., Manns, M.P., Schlag, P.M., Strauss, M. (1999). Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits. J Gene Med, 1, 360-371
6. Corsi, K., Chellat, F., Yahia, L., Fernandes, J.C. (2003). Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials, 24, 1255-1264
7. Dubé, ; D., Francis, M., Leroux, J.C., Winnik, F.M. (2002). Preparation and tumor cell uptake of poly(N-isopropylacrylamide) folate conjugates. Bioconjug Chem, 13, 685-692
8. Dubes, A., Parrot-Lopez, H., Abdelwahed, W., Degobert, G., Fessi, H., Shahgaldian, P., Coleman, A.W. (2003). Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. Eur J Pharm Biopharm, 55, 279-282
9. Escriou V, Ciolina C, Lacroix F, Byk G, Scherman D, Wils P. (1998). Cationic lipid-mediated gene transfer: Effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. Biochim Biophys Acta, 1368, 276-288
10. Hejazi, R., Amiji, M. (2003). Chitosan-based gastrointestinal delivery systems. J Contr Rel, 89, 151-165
11. Jeong, J.H., Kim, S.W., Park, T.G. (2003). A new antisense oligonucleotide delivery system based on self-assembled ODN-PEG hybrid conjugate micelles. J Contr Rel, 93, 183-191
12. Jooss, K., Chirmule, N. (2003). Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy. Gene Ther, 10, 955-963
13. Ke, C.Y., Mathias, C.J., Green, M.A. (2003). The folate receptor as a molecular target for tumor-selective radionuclide delivery. Nucl Med Biol, 30, 811-817
14. Komatsu, H., Kitajima, A., Okada, S. (1995). Pharmaceutical characterization of commercially available intravenous fat emulsions: Estimation of average particle size, size distribution and surface potential using photon correlation spectroscopy. Chem Pharm Bull, 43, 1412-1415
15. Leamon, C.P. (2002). Fusogenic lipids and vesicles for delivery of pharmaceutical agents. US Patent 6, 379, 698.
16. Lincoln, D.T., Ali, Emadi EM, Tonissen, K.F., Clarke, F.M. (2003). The thioredoxin-thioredoxin reductase system: Over expression in human cancer. Anticancer Res, 23, 2425-2433
17. Liu, W.G., Yao, K.D. (2002). Chitosan and its derivatives-a promising non-viral vector for gene transfection. J Contr Rel, 83, 1-11.
18. Lu, Y., Low, P.S. (2003). Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects. J Contr Rel, 91, 17-29.
19. MacLaughlin, F.C., Mumper, R.J., Wang, J., Tagliaferri, J.M., Gill, I., Hinchcliffe, M., Rolland, A.P. (1998). Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Contr Rel, 56, 259-272
20. Mansouri, S., Cuie, Y., Winnik, F., Shi, Q., Lavigne, P., Benderdour, M., Beaumont, E., Fernandes, J.C. (2006). Characterization of folatechitosan- DNA nanoparticles for gene therapy. Biomaterials, 27, 2060-2065
21. Mao, S., Shuai, X., Unger, F., Simon, M., Bi, D., Kissel, T. (2004). The depolymerization of chitosan: Effects on physicochemical and biological properties. Int J Pharm, 281, 45-54.
22. Mehnert, W., Mäder, K. (2001). Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev, 47, 165-196
23. Müller, R.H., Jacobs, C., Kayser, O. (2001). Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv Drug Deliv Rev, 47, 3-19.
24. Müller, R.H., Mäder, K., Gohla, S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery: A review of the state of the art. Eur J Pharm Biopharm, 50, 161-177
25. Nathwani, A.C., Davidoff, A.M., Hanawa, H., Hu, Y., Hoffer, F.A., Nikanorov, A., Slaughter, C., Ng, C.Y., Zhou, J., Lozier, J.N., Mandrell, T.D., Vanin, E.F., Nienhuis, A.W. (2002). Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood, 100, 1662-1669
26. Pack, D.W., Hoffman, A.S., Pun, S., Stayton, P.S. (2005). Design and development of polymers for gene delivery. Nat Rev Drug Discov, 4, 581-593
27. Qian, Z.M., Li, H., Sun, H., Ho, K. (2002). Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev, 54, 561-587
28. Sapra, P., Allen, T.M. (2003). Ligand-targeted liposomal anticancer drugs. Prog Lipid Res, 42, 439-462
29. Turunen N, Karihtala P, Mantyniemi A, Sormunen R, Holmgren A, Kinnula VL, Soini Y. (2004). Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma. APMIS, 112, 123-132
30. Wang, S., Luo, J., Lantrip, D.A., Waters, D.J., Mathias, C.J., Green, M.A., Fuchs, P.L., Low, P.S. 1997. Design and synthesis of [111In] DTPA-folate for use as tumor targeted radiopharmaceutical. Bioconjug Chem, 8, 673-679
31. Zhong, Z.R., Liu, J., Deng, Y., Zhang, Z.R., Song, Q.G., Wei, Y.X., He, Q. (2007). Preparation and characterization of a novel nonviral gene transfer system: Procationic-liposome-protamine-DNA complexes. Drug Deliv, 14, 177-183
32. Zhou, W., Yuan, X., Wilson, A., Yang, L., Mokotoff, M., Pitt, B., Li, S. (2002). Efficient intracellular delivery of oligonucleotides formulated in folate receptor-targeted lipid vesicles. Bioconjug Chem, 13, 1220-1225